ArazyGroup

Disrupting the MedTech Registration Industry since 1995! We want all of the best medical technology to reach everyone it needs to!

[ArazyGroup @ArazyGroup]

🚀 You Don't Know What You Don't Know... Until Now! #ArazyGroup #MarketReadiness

👉 Learn more about how we can help you achieve global success: https://t.co/pZhxoMlwhO

[ArazyGroup @ArazyGroup]

🔍 Ever pondered if Regulatory Affairs is more than just rules? Unveil the science behind it in our blog! Explore the dynamic world of regulatory compliance and innovation.

Join the conversation now!

#RegulatoryAffairs #RegTechAI #RegTech #Creativity #ArtandScience

[ArazyGroup @ArazyGroup]

The MDD of the Department of Health in Hong Kong made a significant announcement on its website regarding the acceptance of marketing approvals acquired from the Health Sciences Authority (HSA) of Singapore under the MDACS.

Stay up to date at https://t.co/b7xNSvIhkK!

[ArazyGroup @ArazyGroup]

Introducing our first Success Story in a new series! As a young company, they embraced RegTech early on, leveraging its power to propel them globally. Find out how SOFTNETA took their regulatory affairs and product registration game to the next level at https://t.co/11S0XTboya.

[ArazyGroup @ArazyGroup]

🚩 The Council of the EAEU adopted an updated edition of the Rules for conducting clinical and clinical laboratory tests of medical devices for registration within the EAEU.

To stay on top of all the latest regulatory updates, visit https://t.co/6XXKzux7UI.

[ArazyGroup @ArazyGroup]

With a rich history spanning 27 years, we've proudly overseen the successful registration of over 5000 medical devices.

Secure your place today at https://t.co/Wm9nTscYQB

[ArazyGroup @ArazyGroup]

The CMDE issued a significant Notice outlining the recommended path for clinical evaluation of products aligned with the Medical Device Classification Catalog (2024 Supplement).

For the full update and guidance document, visit https://t.co/j1VbBAwxN6

[ArazyGroup @ArazyGroup]

To all the mothers, mother figures, and mothers-to-be who guide and lift us up...

Thank you for your unwavering support and love, today and everyday! Your ability to balance it all with grace is nothing short of inspiring. Happy Mother's Day. 💐

#MothersDay

[ArazyGroup @ArazyGroup]

Medtech consultant… are you seeking a competitive edge?

We have an opportunity for you to expand your offerings with Regulatory Technology and AI Solutions!

👉 Curious to learn more? Visit https://t.co/3lfZ85azhD for the full details and application.

[ArazyGroup @ArazyGroup]

Join us at an exclusive live event!

You do not want to miss our next meeting on Tuesday, May 21st. Secure your place today at https://t.co/mdlcCwNoPy!

[ArazyGroup @ArazyGroup]

The latest release from the Medical Device Authority (MDA) of Malaysia on February 19, 2024, introduces the first edition of the Guidance for Placement of HIV Self-Test (HIVST) Kit In Malaysia Market (MDA/GD/0065).

For the guidance document, visit https://t.co/oyPhvdCXF5.

[ArazyGroup @ArazyGroup]

🚩 We have an exciting regulatory update in Australia!

On December 7, 2023, the TGA released Version 2.0 of the Guidance on Boundary and Combination Products. This document delves into the regulatory framework surrounding boundary and combination products within Australia.

[ArazyGroup @ArazyGroup]

Introducing our first Success Story in a new series, featuring Softneta!

Find out how Softneta took their regulatory affairs and product registration game to the next level at https://t.co/wkPEdTX6OG.

#ArazyGroup #SuccessStory #RegulatoryAffairs #MedTech #RegTech #RegTechAI

[ArazyGroup @ArazyGroup]

Happy Passover 🕊️🌷 פסח כשר ושמח

Passover is a time for reflection, growth, and renewal. It is an opportunity to take the time to appreciate loved ones, health and freedom.

Chag Pesach Sameach!

[ArazyGroup @ArazyGroup]

Exciting news for the medical device industry in Brazil!

The adoption of Normative Instruction 290, based on Draft Resolution 1200, marks a significant step towards streamlining the registration process for medical devices and IVDs.

Visit https://t.co/kdrdNDZ6Qf for more info!

[ArazyGroup @ArazyGroup]

Whether you're embarking on your regulatory journey or a seasoned pro eager to exchange wisdom, there's a spot for you in the Regulatory Rockstar Movement.

Join a tribe of dynamic regulatory minds, shaping the future of healthcare at https://t.co/x0WFlo2EbW.

[ArazyGroup @ArazyGroup]

On December 7, 2023, the NMPA issued Announcement No. 153, titled "Announcement of the State Food and Drug Administration on the Release of Quality Management Standards for Medical Device Operations (2023 No. 153)."

For the FULL resource, visit https://t.co/1L28pQl7p8.

[ArazyGroup @ArazyGroup]

We know how busy you are, and how challenging the industry can be, which is why we created an epicentre for regulatory affairs professionals, where innovation, collaboration, and personal growth unite.

Join the movement at https://t.co/sBRa7qLBWZ!

[ArazyGroup @ArazyGroup]

🚀 Calling all Regulatory Affairs Professionals in the MedTech industry!

Don't miss out on this incredible chance to make a difference. Join the Regulatory Rockstar Movement at https://t.co/w4L2hYCsPD to gain access to this exclusive program.

[ArazyGroup @ArazyGroup]

🚩 Regulatory Update!

On February 6, 2024, the SFDA released version 3 of Guidance MDS – G020, focusing on SFDA Recognized Standards that support premarket submissions for medical devices.

Find Saudi-Arabia specific regulatory information at https://t.co/RmmoXGRydy.